-
Loading metrics
CCNA2 Is a Prognostic Biomarker for ER+ Breast Cancer and Tamoxifen Resistance
- Tian Gao,
- Yong Han,
- Ling Yu,
- Sheng Ao,
- Ziyu Li,
- Jiafu Ji
x
- Published: March 12, 2014
- https://doi.org/10.1371/journal.pone.0091771
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Loading metrics